Nordea underwrites Pronova loan
Norwegian pharmaceutical firm Pronova BioPharm is syndicating a Nkr2.38bn (Eu296m, $407m) five year loan that Nordea has underwritten.
The facility, which is split into a Nkr1.78bn multi-currency term loan and a Nkr500m multicurrency revolver, is being marketed to a small group of banks, including new lenders. Syndication is expected to close at the end of the month.The term loan is split into a Nkr680m tranche ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com